Effects of Sedante Neo Therapy on Pain, Range of Motion and Quality of Life in Patients With Non Specific Low Back Pain.

Launched by RIPHAH INTERNATIONAL UNIVERSITY · May 15, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a treatment called SADANTE neo therapy on people who have non-specific low back pain. The goal is to see how this therapy can help reduce pain, improve movement, and enhance overall quality of life. The study is currently looking for participants who are between 20 and 40 years old, regardless of gender, and who experience mild to moderate low back pain. To qualify, participants should have certain scores that measure their pain and ability to function, and they should not have other serious health conditions or previous surgeries in the lower back.

If you decide to join the trial, you can expect to receive the SADANTE neo therapy and be monitored for its effects on your pain levels, how well you can move, and how your daily life is affected. This research is important because it aims to find new ways to help people with low back pain, a common issue that many face. If you meet the eligibility criteria and are interested, this could be an opportunity to contribute to valuable research while potentially experiencing relief from your symptoms.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age group of 20 yeras to 40 years.
• • Both male and female included.
• • Having non-specific low back pain.
• • Having SF-MPQ score 1and 2 (1 means mild, 2 means moderate)
• • Having ODI score 5 to 24
• • Having SF-36 healty survey score below 50
• • Having range of motion below normal.
• Exclusion Criteria:
• • Below 20 years and above 40 years patient are excluded
• • Cervical, knee pain and other conditions excluded.
• • Children are excluded
• • Red flags ( tuberculosis, carcinoma heart disease etc) excluded
• • -Open sores
• • Psychiatric diseases such as depression, phobias
• • Patient with history of surgery in lumber region